Clinical Trials on Growth Faltering

Total 1135 results

ANRS, Emerging Infectious Diseases

Completed

Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety

Growth and Development

Burkina Faso, South Africa, Uganda, Zambia
Università degli Studi di Ferrara

Unknown

Human Milk Lipid Profile Assessment and Influences of Mother's Diet

Diet Habit | Breastfeeding | Human Milk | Infant Growth | Fatty Acid

Italy
University of Zurich

Completed

Validation of a Smart Phone App to Non-invasively Measure the Size of Children

Growth and Development

Switzerland
University of Patras
European Society for Paediatric Research (ESPR)

Recruiting

IUGR, Respiratory Muscle Function, and Exercise Capacity in Childhood

Intrauterine Growth Restriction | Cardiopulmonary Disease

Greece
Central Hospital, Nancy, France

Completed

First Trimester Screening for Preeclampsia and Intrauterine Growth RestrIction Using Three Dimensional Doppler Angiography (SPIRIT)

Pre-Eclampsia

France
Fundació Institut de Recerca de l'Hospital de la...
Spanish Clinical Research Network - SCReN

Completed

First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction

Preeclampsia | Intrauterine Growth Restriction

Spain
Assiut University

Unknown

Predictors of Intrauterine Growth Restriction

Pre-Eclampsia

Egypt
International Food Policy Research Institute

Completed

Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing MNCH Platform in Bangladesh

Premature Birth | Small-for-gestational Age | Poor Fetal Growth

United States
Fetal Medicine Foundation
Wright State University

Completed

First Trimester Prediction of Preeclampsia and Fetal Growth Restriction

Preeclampsia | Fetal Growth Restriction

United States
University of Tennessee Graduate School of Medicine

Recruiting

Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy

Fetal Growth Retardation | Fetal Growth Complications | Placental Insufficiency

United States
Hospices Civils de Lyon

Unknown

Necrotizing Enterocolitis in Fetuses With Intrauterine Growth Restriction (ECUN)

Necrotizing Enterocolitis

France
Assiut University

Not yet recruiting

Growth Pattern and Characteristics of Cardiac Pediatric Patients

Growth Disorders
Second Affiliated Hospital, School of Medicine,...
Nantong University; Taizhou Hospital; The Second Affiliated Hospital of Kunming... and other collaborators

Recruiting

Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site

Wound Healing | Fibroblast Growth Factors

China
Children's National Research Institute

Active, not recruiting

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

Growth Disorders

United States
University of Karachi
Advanced Education & Research Center

Completed

To Observe the Psychophysiological Alterations in Traumatic Stress Subjects

Traumatic Stress, Post-Traumatic Growth

Pakistan
Merck KGaA, Darmstadt, Germany
Merck Ltd., Taiwan; Merck Pte. Ltd., Singapore; PT Merck Tbk., Indonesia, an...

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore) (ECOS TW ID SG)

Growth Disorders

Singapore, Taiwan, Indonesia
Merck KGaA, Darmstadt, Germany
Merck Kft., Hungary

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary (ECOS HUN)

Growth Disorders

Hungary
Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy (ECOS ITA)

Growth Disorders

Italy
Merck KGaA, Darmstadt, Germany
Merck spol. s r.o., Slovakia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia (ECOS SVK)

Growth Disorders

Slovakia
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France (ECOS FRA)

Growth Disorders

France
Merck KGaA, Darmstadt, Germany
Merck Quimica Argentina S.A.I.C

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina (ECOS ARG)

Growth Disorders

Argentina
Merck KGaA, Darmstadt, Germany
Merck S.A. de C.V., Mexico

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico (ECOS MEX)

Growth Disorders

Mexico
Merck KGaA, Darmstadt, Germany
Merck A.E., Greece

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece (ECOS GRE)

Growth Disorders

Greece
University Hospital of Split

Completed

Indicators of Growth, Nutritional Status and Comorbide Disorders of Newborns With Down Syndrome (DownSy)

Down Syndrome,Auxological Indexes, Auxological Parametars, Intrauterine Growth Restriction

Croatia
Tel-Aviv Sourasky Medical Center

Unknown

Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity

Pregnancy Complications | Preeclampsia | Placental Abruption | Intrauterine Fetal Death | Intrauterine Fetal Growth Restriction

Israel
University of Florence

Terminated

LMWH to Prevent Preeclampsia and Fetal Growth Restriction

Preeclampsia
Abbott Nutrition

Not yet recruiting

Preterm Infants Fed a Human Milk Fortifier

Growth
Rabin Medical Center

Recruiting

Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls

Low Weight | Growth Problem

Israel
Merck KGaA, Darmstadt, Germany
Merck S.A. Columbia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia (ECOS COL)

Growth Disorders

Colombia
Merck KGaA, Darmstadt, Germany
Merck A.B., Sweden

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden (ECOS SWE)

Growth Disorders

Sweden
Merck KGaA, Darmstadt, Germany
Merck spol.s.r.o., Czech Republic

Completed

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic (ECOS CZ)

Growth Disorders

Czechia
Merck KGaA, Darmstadt, Germany
Merck Serono Australia Pty Ltd

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia (ECOS AUS)

Growth Disorders

Australia
Merck KGaA, Darmstadt, Germany
Merck Gesellschaft mbH, Austria

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria (ECOS AUT)

Growth Disorders

Austria
Merck KGaA, Darmstadt, Germany
EMD Serono, a division of EMD Inc., Canada

Completed

A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment (ECOS CAN)

Growth Disorders

Canada
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ LLC

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East (ECOS UAE)

Growth Disorders

Germany
Genentech, Inc.

Completed

National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin

Growth Disorders
University of Alabama at Birmingham
Genentech, Inc.

Completed

Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent

Growth Disorders
Maastricht University Medical Center

Unknown

Women Specific Cardiac Recovery After Preeclampsia (WeCare)

Pregnancy | Pre-Eclampsia | Intrauterine Growth Restriction | HELLP Syndrome

Netherlands
Central Hospital, Nancy, France

Unknown

Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies (EVUPA)

Preeclampsia | Intra-uterine Growth Restriction

France
Skane University Hospital
University of California, Davis; Umeå University; Arla Foods

Active, not recruiting

Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula

Sleep | Growth | Infection

Sweden
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK (ECOS UK)

Growth Disorders

United Kingdom
Merck KGaA, Darmstadt, Germany

Completed

Saizen® E-Device User Trial

Growth Disorders
Merck KGaA, Darmstadt, Germany
Merck Ltd.

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea (ECOS KOR)

Growth Disorders

Korea, Republic of
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain (ECOS ESP)

Growth Disorders

Spain
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment (ECOS CHN)

Growth Disorders

China
University of Palermo

Completed

Adrenal Function in GHD Children

Growth Hormone Treatment | Adrenal; Functional Disturbance

Italy
International Centre for Diarrhoeal Disease Research...

Completed

Promotion of Complimentary Feeding Practices in Bangladesh

Growth Disorders

Bangladesh
UMC Utrecht
Stichting Achmea Gezondheidszor

Recruiting

OPtimal TIming of COrticosteroids in Early-onset Fetal Growth REstriction: the OPTICORE Study (OPTICORE)

Fetal Growth Retardation

Netherlands
Central Hospital, Nancy, France

Completed

Doppler at the Diagnosis in Predicting Perinatal Outcomes in Early and Late-onset Fetal Growth Restriction

Fetal Growth Retardation

France
Istanbul Bakirkoy Maternity and Children Diseases...

Completed

Doppler and AFV for Outcome Prediction ın FGR

Fetal Growth Retardation

Turkey

Clinical Trials on Growth Faltering

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations